FDA Approves Lemborexant (Dayvigo) for Insomnia
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
Covering identification, assessment, and interventions for adults with suspected or confirmed autism spectrum disorder
Hispanic/Latinx and Black patients are underrepresented in immune checkpoint inhibitor clinical trials, but recent years have seen some improvement in their inclusion.
Do you know every organ system that immune-related adverse effects can affect?
A common food dye turned mice see-through, a “stunning” finding that could revolutionize imaging techniques in medicine.
Did you know that activating EGFR mutations demonstrate differential sensitivity to EGFR-directed targeted therapies?
Bariatric surgery before pregnancy was associated with a higher risk for premature and small for gestational age infants.
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
ECT has been a lifesaving treatment for severe depression, but its workings remained a mystery. Researchers have uncovered the mechanisms behind its effects, potentially enhancing…
Updated summary covering diagnosis, insulin therapy, and blood glucose management, plus new recommendations on periodontitis
The 3rd International Congress on ATTR Amyloidosis (ICAA) returns this October. Join us for a day of engaging, interactive sessions on our virtual platform, exploring…